{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:50:05Z","timestamp":1790657405739,"version":"4.1.0"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Previous observational epidemiological studies have identified a potential association between inflammatory bowel disease (IBD) and sarcoidosis. Nonetheless, the precise biological mechanisms underlying this association remain unclear. Therefore, we adopted a Mendelian randomization (MR) approach to investigate the causal relationship between IBD with genetic susceptibility to sarcoidosis, as well as to explore the potential mediating role.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The genetic associations were obtained from publicly available genome-wide association studies (GWASs) of European ancestry. The IBD dataset has 31,665 cases and 33,977 controls, consisting of 13,768 individuals with ulcerative colitis (UC) and 17,897 individuals with Crohn\u2019s disease (CD). The genetic associations of sarcoidosis with 4,854 cases and 446,523 controls. A bidirectional causality between IBD and sarcoidosis was implemented to be determined by a two-sample MR approach. The inverse variance weighted (IVW) method was utilized as the main statistical method, and a series of sensitivity analyses were performed to detect heterogeneity and horizontal pleiotropy. A two-step MR approach was used to investigate whether the mediating pathway from IBD to sarcoidosis was mediated by PBC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The forward MR analysis indicated that genetic predisposition to IBD was significantly linked to an increased risk of sarcoidosis (OR = 1.088, 95% CI: 1.023\u20131.158, <jats:italic>p<jats:sub>IBD-sar<\/jats:sub><\/jats:italic> = 7.498e-03). Similar causal associations were observed in CD (OR = 1.082, 95% CI: 1.028\u20131.138, <jats:italic>p<jats:sub>CD-sar<\/jats:sub><\/jats:italic> = 2.397e-03) and UC (OR = 1.079, 95% CI: 1.006\u20131.158, <jats:italic>p<jats:sub>UC-sar<\/jats:sub><\/jats:italic> = 0.034). Reverse MR analysis revealed that genetic susceptibility to sarcoidosis was correlated with an augmented risk of CD (OR = 1.306, 95% CI: 1.110\u20131.537, <jats:italic>p<jats:sub>sar-CD<\/jats:sub><\/jats:italic> = 1.290e-03) but not IBD or UC. The mediation analysis via two-step MR showed that the causal influence of IBD and CD on sarcoidosis effects was partly mediated by PBC, and the mediating effect was 0.018 (95% CI: 0.005\u20130.031, <jats:italic>p<\/jats:italic> = 7.596e-03) with a mediated proportion of 21.397% in IBD, and 0.014 (95% CI: 0.004\u20130.024, <jats:italic>p<\/jats:italic> = 7.800e-03) with a mediated proportion of 17.737% in CD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The MR analysis provided evidence substantiating the causal effect of IBD (CD and UC) on an increased risk of sarcoidosis, with PBC playing a mediating role in IBD and CD. However, sarcoidosis only enhances the risk of developing CD, but not IBD or UC. These findings illuminate the etiology of sarcoidosis and contribute to the management of IBD patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1448724","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T09:54:39Z","timestamp":1725357279000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Causal association of inflammatory bowel disease with sarcoidosis and the mediating role of primary biliary cholangitis"],"prefix":"10.3389","volume":"15","author":[{"given":"Jiazhi","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2340","article-title":"The genetics and immunopathogenesis of inflammatory bowel disease","volume":"8","author":"Cho","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11582","article-title":"Anderson CA et\u00a0al: Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41575-023-00854-4","article-title":"Deciphering the different phases of preclinical inflammatory bowel disease","volume":"21","author":"Rudbaek","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-018-0604-3","article-title":"Mason AL et\u00a0al: Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases","volume":"7","author":"Armstrong","year":"2019","journal-title":"Microbiome"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13629","article-title":"Sarcoidosis: Epidemiology and clinical insights","volume":"293","author":"Rossides","year":"2023","journal-title":"J Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12423","article-title":"Sarcoidosis is associated with lower risks of penetrating disease and colectomy in hospitalized patients with inflammatory bowel disease","volume":"4","author":"Jiang","year":"2020","journal-title":"JGH Open"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2006.11.007","article-title":"Pulmonary manifestations of inflammatory bowel disease","volume":"39","author":"Sostegni","year":"2007","journal-title":"Dig Liver Dis"},{"key":"B10","article-title":"Pulmonary function tests, high-resolution computed tomography findings and inflammatory bowel disease","volume":"69","author":"Tunc","year":"2006","journal-title":"Acta Gastroenterol Belg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35396","article-title":"Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes","volume":"123","author":"Orchard","year":"2002","journal-title":"Gastroenterology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Johns CJ et\u00a0al: Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"B13","article-title":"Sarcoidosis and crohn's disease","volume":"64","author":"Mitchell","year":"1971","journal-title":"Proc R Soc Med"},{"key":"B14","article-title":"Crohn's disease-associated interstitial lung disease mimicking sarcoidosis: a case report and review of the literature","volume":"33","author":"Thao","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040429","article-title":"Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis","volume":"201","author":"Song","year":"2005","journal-title":"J Exp Med"},{"key":"B17","article-title":"Association of sarcoidosis and ulcerative colitis: a review of 20 cases","volume":"30","author":"Jarrot","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.01.008","article-title":"Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab","volume":"6","author":"Fok","year":"2012","journal-title":"J Crohns Colitis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2019.05.002","article-title":"Primary biliary cholangitis in patients with inflammatory bowel disease","volume":"44","author":"Liberal","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddab273","article-title":"Identification of causal metabolites related to multiple autoimmune diseases","volume":"31","author":"Yu","year":"2022","journal-title":"Hum Mol Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i4.878","article-title":"Primary biliary cirrhosis and ulcerative colitis: a case report and review of literature","volume":"9","author":"Xiao","year":"2003","journal-title":"World J Gastroenterol"},{"key":"B23","article-title":"Coexistence of primary biliary cirrhosis and sarcoidosis","volume":"153","author":"Leff","year":"1990","journal-title":"West J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/BF01535764","article-title":"Sarcoidosis and primary biliary cirrhosis. Coexistence in a single patient","volume":"33","author":"Sherman","year":"1988","journal-title":"Dig Dis Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1068198","article-title":"[Association of primary biliary liver cirrhosis with sarcoidosis\u2013separate diseases or a new nosological entity]","volume":"112","author":"Ormann","year":"1987","journal-title":"Dtsch Med Wochenschr"},{"key":"B26","article-title":"[Primary biliary cirrhosis and sarcoidosis. Association or unique disease]","volume":"8","author":"Bories","year":"1984","journal-title":"Gastroenterol Clin Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198303103081011","article-title":"Sarcoidosis and primary biliary cirrhosis. Associated disorders","volume":"308","author":"Maddrey","year":"1983","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.07.031","article-title":"Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases","volume":"58","author":"Kishor","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/path.5421","article-title":"The use of Mendelian randomisation to identify causal cancer risk factors: promise and limitations","volume":"250","author":"Gala","year":"2020","journal-title":"J Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/ije\/dyv071","article-title":"Mendelian randomization studies: a review of the approaches used and the quality of reporting","volume":"44","author":"Boef","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1177\/0962280206077743","article-title":"Mendelian randomization as an instrumental variable approach to causal inference","volume":"16","author":"Didelez","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.055","article-title":"Gervais O et\u00a0al: An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs","volume":"75","author":"Cordell","year":"2021","journal-title":"J Hepatol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1086\/519795","article-title":"Daly MJ et\u00a0al: PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101 e111","DOI":"10.1016\/j.neurobiolaging.2020.09.025","article-title":"Herpes simplex virus and Alzheimer's disease: a Mendelian randomization study","volume":"99","author":"Kwok","year":"2021","journal-title":"Neurobiol Aging"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14430","article-title":"Ma J et\u00a0al: Schizophrenia mediating the effect of smoking phenotypes on antisocial behavior: A Mendelian randomization analysis","volume":"30","author":"Zhang","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.12468","article-title":"Adiposity as a risk factor for inflammatory bowel disease and the mediating effect of metabolic and inflammatory status: A population-based cohort study","volume":"11","author":"He","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165411","article-title":"Effect of alcoholic intoxication on the risk of inflammatory bowel disease: A nationwide retrospective cohort study","volume":"11","author":"Hsu","year":"2016","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjac193","article-title":"Association of waist circumference with the risk of inflammatory bowel disease: a nationwide cohort study of 10 million individuals in Korea","volume":"17","author":"Je","year":"2023","journal-title":"J Crohns Colitis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12875","article-title":"Body mass index and risk of inflammatory bowel disease: A systematic review and dose-response meta-analysis of cohort studies of over a million participants","volume":"20","author":"Rahmani","year":"2019","journal-title":"Obes Rev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1368401","article-title":"Association of diet and outdoor time with inflammatory bowel disease: a multicenter casecontrol study using propensity matching analysis in China","volume":"12","author":"Chu","year":"2024","journal-title":"Front Public Health"},{"key":"B47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/healthcare9010035","article-title":"Impact of body mass index on the development of inflammatory bowel disease: A systematic review and dose-response analysis of 15.6 million participants","volume":"9","author":"Bhagavathula","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-018-0850-0","article-title":"Narawane N et\u00a0al: Risk factors for inflammatory bowel disease: A prospective multi-center study","volume":"37","author":"Amarapurkar","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2008.09.001","article-title":"The prevalence of hyper- and hypothyroidism in patients with ulcerative colitis","volume":"2","author":"Casella","year":"2008","journal-title":"J Crohns Colitis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23722","article-title":"Khera AV et\u00a0al: Causal effect of adiposity on the risk of 19 gastrointestinal diseases: a Mendelian randomization study","volume":"31","author":"Kim","year":"2023","journal-title":"Obes (Silver Spring)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz152","article-title":"Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease-A systematic review and meta-analysis","volume":"14","author":"Alinaghi","year":"2020","journal-title":"J Crohns Colitis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1376139","article-title":"Casual associations of thyroid function with inflammatory bowel disease and the mediating role of cytokines","volume":"15","author":"Wu","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v14.i9.1747","article-title":"Alcohol intake is associated with a decreased risk of developing primary biliary cholangitis","volume":"14","author":"French","year":"2022","journal-title":"World J Hepatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1527-3350","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.184218","article-title":"Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations","volume":"59","author":"Prince","year":"2010","journal-title":"Gut"},{"key":"B56","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s12967-024-05247-y","article-title":"Genetic association and causal relationship between multiple modifiable risk factors and autoimmune liver disease: a two-sample mendelian randomization study","volume":"22","author":"Gao","year":"2024","journal-title":"J Transl Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000715","article-title":"Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors","volume":"26","author":"Arkema","year":"2020","journal-title":"Curr Opin Pulm Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.537382","article-title":"Sarcoidosis epidemiology: race matters","volume":"11","author":"Hena","year":"2020","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.009","article-title":"The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients","volume":"15","author":"Fallahi","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression","volume":"47","author":"Bowden","year":"2018","journal-title":"Int J Epidemiol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw220","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00049410","article-title":"Schreiber S et\u00a0al: Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes","volume":"37","author":"Fischer","year":"2011","journal-title":"Eur Respir J"},{"key":"B69","doi-asserted-by":"publisher","first-page":"17562848221115312","DOI":"10.1177\/17562848221115312","article-title":"Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations","volume":"15","author":"Bezzio","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-199911000-00009","article-title":"Th1\/th2 cells","volume":"5","author":"Romagnani","year":"1999","journal-title":"Inflammation Bowel Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.163667","article-title":"Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease","volume":"58","author":"Brand","year":"2009","journal-title":"Gut"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izac199","article-title":"The pathogenicity and synergistic action of th1 and th17 cells in inflammatory bowel diseases","volume":"29","author":"Cao","year":"2023","journal-title":"Inflammation Bowel Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"121501","DOI":"10.1016\/j.lfs.2023.121501","article-title":"Cao Y et\u00a0al: Taurohyodeoxycholic acid alleviates trinitrobenzene sulfonic acid induced ulcerative colitis via regulating Th1\/Th2 and Th17\/Treg cells balance","volume":"318","author":"Lv","year":"2023","journal-title":"Life Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15214","article-title":"Coppo C et\u00a0al: Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome","volume":"36","author":"Efe","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1527-3350","article-title":"Th1 cytokine-induced downregulation of PPARgamma in human biliary cells relates to cholangitis in primary biliary cirrhosis","volume":"41","author":"Harada","year":"2005","journal-title":"Hepatology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1527-3350","article-title":"In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset","volume":"25","author":"Harada","year":"1997","journal-title":"Hepatology"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26979","article-title":"Ansari AA et\u00a0al: IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2018.03.002","article-title":"The genetics and epigenetics of primary biliary cholangitis","volume":"22","author":"Tanaka","year":"2018","journal-title":"Clin Liver Dis"},{"key":"B79","doi-asserted-by":"publisher","first-page":"7190","DOI":"10.1038\/s41598-019-43699-1","article-title":"Kluska A et\u00a0al: Common functional alterations identified in blood transcriptome of autoimmune cholestatic liver and inflammatory bowel diseases","volume":"9","author":"Ostrowski","year":"2019","journal-title":"Sci Rep"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15616","article-title":"The causal effects of inflammatory bowel disease on primary biliary cholangitis: A bidirectional two-sample Mendelian randomization study","volume":"43","author":"Zhang","year":"2023","journal-title":"Liver Int"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1448724\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T09:54:46Z","timestamp":1725357286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1448724\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":80,"alternative-id":["10.3389\/fimmu.2024.1448724"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1448724","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]},"article-number":"1448724"}}